Ronald Swanson
Chief Tech/Sci/R&D Officer at TYRA BIOSCIENCES, INC.
Network origin in Ronald Swanson first degree
Entity | Entity type | Industry | |
---|---|---|---|
Public Company | Biotechnology | 23 | |
Johnson & Johnson, Inc.
Johnson & Johnson, Inc. Insurance Brokers/ServicesFinance Johnson & Johnson, Inc. provides insurance brokerage services. The company was founded in 1930 and is headquartered in Mount Pleasant, SC.
11
| Private Company | Insurance Brokers/Services | 11 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Ronald Swanson via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
HOLOGIC, INC. | Medical Specialties | Director of Finance/CFO | |
PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
MERCK KGAA | Pharmaceuticals: Major | Corporate Officer/Principal | |
AGILENT TECHNOLOGIES, INC. | Medical Specialties | Director of Finance/CFO | |
METLIFE, INC. | Multi-Line Insurance | Human Resources Officer | |
ORASURE TECHNOLOGIES, INC. | Medical Specialties | Director/Board Member | |
Bayer Pharmaceuticals Corp. | Corporate Officer/Principal | ||
NovaCardia, Inc.
NovaCardia, Inc. Pharmaceuticals: MajorHealth Technology NovaCardia, Inc. develops drugs to treat cardiovascular diseases. The company provides treatment for the patients by developing and commercializing clinical stage drug diseases. It also develops small molecule drugs. the company was founded in November, 2001 by Eckard Weber & Howard C. Dittrich and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Morgan Stanley & Co. LLC
Morgan Stanley & Co. LLC Investment Banks/BrokersFinance Morgan Stanley & Co. LLC is a registered broker-dealer subsidiary of Morgan Stanley Domestic Holdings, Inc., ultimately owned by Morgan Stanley (NYSE: MS) in the US. Headquartered in New York City, the firm was founded in 1987 and provides debt and equity services including underwriting, M&A advice, securities dealing and brokerage and trade execution. Their client base ranges from large global institutional investors to hedge funds at the cutting edge of innovation in the industry. | Investment Banks/Brokers | Analyst-Equity | |
Domain Associates LLC
Domain Associates LLC Investment ManagersFinance Domain Associates LLC (Domain Associates) is a venture capital firm founded in 1985. The firm is headquartered in Princeton, New Jersey. | Investment Managers | Private Equity Investor | |
The Trustees of Columbia University in The City of New York | College/University | Doctorate Degree | |
University of Oxford | College/University | Graduate Degree | |
Ortho-Clinical Diagnostics, Inc.
Ortho-Clinical Diagnostics, Inc. Medical SpecialtiesHealth Technology Ortho-Clinical Diagnostics, Inc. engages in the manufacture and design of diagnostic, transfusion, clinical equipment, and systems. It provides solutions for screening, diagnosing, monitoring, and confirming diseases early before they put lives at risk. Its products include instrument systems and reagents that screen for AIDS and hepatitis C, as well as blood typing systems. The company was founded in 1939 and is headquartered in Raritan, NJ. | Medical Specialties | Corporate Officer/Principal | |
H.I.G. Capital LLC
H.I.G. Capital LLC Financial ConglomeratesFinance H.I.G. Capital LLC operates as s a private equity and alternative assets investment firm. Its portfolio focuses in private equity, growth equity, real estate, debt or credit, lending, and bio health. The company was founded by Sami W. Mnaymneh and Anthony Tamer in 1993 and is headquartered in Miami, FL. | Financial Conglomerates | Corporate Officer/Principal | |
Nextech Invest AG
Nextech Invest AG Investment ManagersFinance Nextech Invest AG (Nextech) is an independent venture capital firm with headquarters in Zurich, Switzerland. It was founded by Alfred Scheidegger in 1998. Nextech's investors include public pension funds, banks, asset management companies and Swiss and German high-net worth individuals. | Investment Managers | Private Equity Analyst | |
University of California, Los Angeles | College/University | Doctorate Degree | |
Massachusetts Institute of Technology | College/University | Director/Board Member Doctorate Degree Undergraduate Degree | |
Rensselaer Polytechnic Institute | College/University | Undergraduate Degree | |
University of California, Davis | College/University | Undergraduate Degree | |
University of California San Diego | College/University | Undergraduate Degree Graduate Degree | |
University of Central Florida | College/University | Masters Business Admin | |
University of Florida | College/University | Undergraduate Degree | |
University of South Florida | College/University | Masters Business Admin | |
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Pharmaceuticals: Major | President | |
University of Zagreb | College/University | Doctorate Degree | |
MetLife Foundation | Director/Board Member | ||
Massachusetts Biotechnology Council
Massachusetts Biotechnology Council Miscellaneous Commercial ServicesCommercial Services Massachusetts Biotechnology Council is a premier life sciences and healthcare hub with over 1,600 members dedicated to preventing, treating, and curing diseases through transformative science and technology. The non-profit company is based in Cambridge, MA. MassBio works to advance policy and promote education while providing member programs, events, industry information, and services. The company's mission is to advance Massachusetts' leadership in the life sciences to grow the industry, add value to the healthcare system, and improve patient lives. Founded in 1985 by James P. Sherblom, the CEO is Kendalle Burlin O'Connell. | Miscellaneous Commercial Services | Director/Board Member | |
Daiichi Sankyo, Inc.
Daiichi Sankyo, Inc. Pharmaceuticals: MajorHealth Technology Daiichi Sankyo, Inc. manufactures and supplies pharmaceutical products. It markets therapies in hypertension, dyslipidemia, diabetes, thrombosis, stroke risk reduction, acute coronary syndrome, opioid-induced constipation, IV iron therapy and metastatic melanoma. The company was founded in 2006 and is headquartered in Basking Ridge, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal | |
H.I.G. BioHealth Partners LLC
H.I.G. BioHealth Partners LLC Investment ManagersFinance H.I.G. BioHealth Partners LLC (H.I.G. BioHealth Partners) is a private equity and venture capital subsidiary of H.I.G. Ventures LLC founded in 1993. The firm is headquartered in Miami, Florida with additional offices around the globe. | Investment Managers | Private Equity Investor | |
ImaginAb, Inc.
ImaginAb, Inc. Medical SpecialtiesHealth Technology ImaginAb, Inc. develops engineered antibody fragments for diagnostic imaging and novel therapeutic applications. It products offer actionable data to facilitate diagnosis of disease, inform better treatment decisions, and monitor response to therapy. The firm also offers a range of pre-clinical (animal imaging) reagents for use with microPET, microSPECT, and optical imaging systems. The company was founded by Christian P. Behrenbruch, Tove Olafsen, Anna M. Wu, and Robert E. Reiter in 2007 and is headquartered in Inglewood, CA. | Medical Specialties | Director/Board Member | |
Harvard Business School | College/University | Masters Business Admin Masters Business Admin | |
CIDARA THERAPEUTICS, INC. | Pharmaceuticals: Other | Director/Board Member Corporate Officer/Principal | |
University of Wisconsin Parkside | College/University | Undergraduate Degree | |
SIENNA BIOPHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Founder | |
CinRx Pharma LLC
CinRx Pharma LLC Pharmaceuticals: MajorHealth Technology CinRx Pharma LLC develops biopharmaceutical products. It provides therapeutics in a novel way that meets the modern paradigm of drug development. The company was founded by Jonathan L. Isaacsohn in 2015 and is headquartered in Cincinnati, OH. | Pharmaceuticals: Major | Director-Back Office Operation Chief Tech/Sci/R&D Officer | |
MOLECULAR TEMPLATES, INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
Primmune Therapeutics, Inc.
Primmune Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Primmune Therapeutics, Inc. develops small molecules, orally administered toll-like receptor for cancer immunotherapy and tumors. The firm offers treatment and prevention of viral infections. The company was founded by Paulo Rangel, James Appleman, and Stephen Webber in October, 2017 and is headquartered in San Diego, CA. | Miscellaneous Commercial Services | Director/Board Member | |
State Theatre New Jersey | Director/Board Member | ||
Ambagon Therapeutics, Inc.
Ambagon Therapeutics, Inc. BiotechnologyHealth Technology Ambagon Therapeutics, Inc. provides healthcare services. It specializes in biotechnology. The company is headquartered in San Francisco, CA. | Biotechnology | Director/Board Member | |
Alpha-9 Oncology, Inc.
Alpha-9 Oncology, Inc. Miscellaneous Commercial ServicesCommercial Services Alpha-9 Theranostics, Inc. operates as a clinical stage radiopharmaceutical company. It engages in developing breakthrough targeting agents for cancer imaging by positron emission tomography (PET) and therapy using targeted radioisotopes. The company was founded by Fran?ois B?nard, David Perrin, Kuo-Shyan Lin, and Ian McBeath and is headquartered in Vancouver, Canada. | Miscellaneous Commercial Services | Director/Board Member | |
Mbrace Therapeutics, Inc.
Mbrace Therapeutics, Inc. BiotechnologyHealth Technology Mbrace Therapeutics, Inc. is an American company that specializes in antibody discovery methodology. The company's approach, called SPARTA, overcomes several challenges to generate human antibodies that can be quickly translated into clinical applications. Mbrace Therapeutics was founded by Renata Pasqualini, Isan Chen, and Wadih Arap, with Isan Chen serving as the CEO since incorporation. | Biotechnology | Director/Board Member Founder | |
PANACEA ACQUISITION CORP. II | Financial Conglomerates | Director/Board Member | |
EMD Serono Canada, Inc. | Chief Executive Officer | ||
Precede Biosciences, Inc.
Precede Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Precede Biosciences is a company that aims to improve success rates in drug development and clinical practice by breaking down the barriers to precision medicine. The company is based in Boston, MA. The company seeks to redefine what can be learned from a simple blood draw to better target medicines to the right patients. Precede Biosciences is revolutionizing precision medicine by revealing unprecedented insights into disease-defining biology from a simple blood test. The CEO of the company is Rehan Verjee. | Miscellaneous Commercial Services | Chief Executive Officer |
Statistics
International
United States | 44 |
Canada | 3 |
Germany | 2 |
United Kingdom | 2 |
Switzerland | 2 |
Sectoral
Health Technology | 22 |
Consumer Services | 13 |
Finance | 9 |
Commercial Services | 5 |
Operational
Director/Board Member | 141 |
Corporate Officer/Principal | 58 |
Independent Dir/Board Member | 29 |
Undergraduate Degree | 24 |
Chairman | 19 |
Most connected contacts
Insiders | |
---|---|
Nina Kjellson | 49 |
Ronald Williams | 46 |
Robert More | 42 |
Alan Fuhrman | 17 |
Elizabeth Adefioye | 16 |
Gilla Kaplan | 12 |
Esther van den Boom | 12 |
Jake Simson | 11 |
Hiroomi Tada | 9 |
Isan Chen | 8 |
Nenad Sarapa | 8 |
Susan Podlogar | 8 |
Rehan Verjee | 7 |
Siddarth Subramony | 7 |
Melissa McCracken | 7 |
- Stock Market
- Insiders
- Ronald Swanson
- Company connections